Stay updated with breaking news from Eva Kalias. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pratteln, Switzerland, February 28, 2022 - Santhera Pharmaceuticals (SIX: SANN) announces the signing of an agreement with SEAL Therapeutics for a gene therapy approach targeting congenital muscular dystrophy.
Investegate announcements from Santhera Pharmaceuticals Holdi, Santhera Completes Repayment of 2017/22 Convertible Bonds
Pratteln, Switzerland, February 18, 2022 - Santhera Pharmaceuticals (SIX: SANN) announces full redemption of its senior unsecured convertible bonds (the 2017/22 Bonds, ISIN CH0353955195), effective
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Pratteln, Switzerland, December 15, 2021 - Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders have approved all proposals by the Board of Directors at the Extraordinary General Meeting